Ubenimex in Adult Patients With Secondary Lymphedema of The Lower

To evaluate the efficacy of ubenimex in patients with secondary leg lymphedema To evaluate the safety and tolerability of ubenimex in patients with secondary leg lymphedema

November 16, 2016

  • Clinical Trial Information

    Trial Contact: Quintiliani, Jennifer

    Trial Phone: 321.843.2026

  • Age Group: Adult

    Phase: Drug: Phase II

    Principal Investigator: Richard D Klein, MD

    Sub Investigators: Kenneth R Lee, MD;

    IRB No: 16.080.07

    Secondary Protocol No: EIG-UBX-003

    Applicable Disease Sites: Lymphedema